Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prana Principle appears to have been a consumer wellness brand focused on hemp-derived cannabidiol products rather than a drug-development biotech or pharmaceutical company. Publicly available evidence links the brand to APAX OTC Business Development and describes a portfolio of CBD ingestibles, topicals, beauty products, and pet-focused wellness products marketed in the United States. Historical coverage mentions products aimed at pain, sleep, and skincare support, including formulations combining CBD with ingredients such as curcumin or melatonin. Available evidence does not indicate a therapeutic R&D pipeline, regulated clinical-stage assets, or a conventional biotech platform. The brand now appears to have limited or no active standalone corporate presence, so many company-level details are not publicly verifiable.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prana Principle.